Clinical trials
Phase 2 Hematologic Diseases trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 3 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Seagen Inc. | 4 |
| Cogent Biosciences, Inc. | 2 |
| Novartis Pharmaceuticals | 2 |
| Sierra Oncology LLC - a GSK company | 2 |
| Cellectar Biosciences, Inc. | 1 |
| Institut Paoli-Calmettes | 1 |
| Nantes University Hospital | 1 |
| Takeda | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Diseases | 14 |
| Leukemia | 4 |
| Lymphoma | 4 |
| Lymphoma, Non-Hodgkin | 4 |
| Myeloproliferative Disorders | 4 |
| Bone Marrow Diseases | 3 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 |
| Leukemia, Myeloid | 3 |
| Neoplasms | 3 |
| Hodgkin Disease | 2 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.